CRO/CMO정보
home > 미사용컨텐츠> 시장정보> 기업 및 바이어정보> CRO/CMO정보
- 글자크기
[국외]Corporate General Information
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2013-01-30 | 조회수 | 133 |
원문 | 제약산업선진화지원 | ||
출처 | http://pias.khidi.or.kr/jsp/sub_5_1_2_2.jsp?com_idx=36 |
Corporate General Information
Corporate Name |
McGuireWoods LLP |
||||
Corporate Ownership |
Private Company |
||||
Head Office Address |
One James Center, 901 East Cary Street, Richmond, Virginia 23219-4030 |
||||
Facilities City & Country |
U.K. 외 다수나라 다수지역 |
||||
Korean Business Office |
None |
||||
Web-site Address |
|||||
No. of Employees |
As of November 28, 2011, McGuireWoods had 437 partners and 1557 others (including non-partner attorneys as well as administrative staff firmwide). These numbers include subsidiaries McGuireWoods Consulting, and McGuireWoods Capital Group. |
||||
Financial Status |
Sales Revenue in 2010 |
Capital |
Dept-equity Ratio |
||
- |
- |
- |
|||
Contact |
Name |
Joe McMenamin |
|||
Address |
McGuireWoods LLP, One James Center, 901 East Cary St. Richmond, VA 23219 |
||||
Telephone |
804.775.1015 |
||||
|
jmcmenamin@mcguirewoods.com |
||||
Company History |
|||||
|
|||||
Company Description & Organization |
|||||
|
Corporate Service & Business Area
Corporate Main |
Contract Research & Development |
Contract Manufacturing |
Contract Sales & Marketing |
Consulting |
|||||
|
|||||||||
Geographical Business Area |
Contract Research & Development |
Contract Manufacturing |
Contract Sales & Marketing |
Consulting |
|||||
US |
US |
US |
US |
||||||
Canada |
Canada |
Canada |
Canada |
||||||
EU |
EU |
EU |
EU |
||||||
Asia |
Asia |
Asia |
Asia |
||||||
Global |
Global |
Global |
Global |
||||||
Other |
Other |
Other |
Other |
||||||
Focusing Contract Service Area |
Contract Research & Development |
Contract Manufacturing |
Contract Sales & Marketing |
Consulting |
|||||
Research |
API |
APIs |
R&D |
||||||
Pre-Clinical |
R&D Strategy & Management |
||||||||
Pre-clinical Test Sample |
|||||||||
Phase I |
Clinical Trials |
||||||||
Phase II |
Clinical Test Sample |
Finished Products |
Regulatory Affairs |
||||||
Phase III |
Business Development |
||||||||
Finished Product |
|||||||||
Phase IV |
Sales & Marketing |
||||||||
Corporate Product Area |
New Drug |
Biologics |
Herbal Medicine |
Biosimilars |
|||||
NCE |
NME |
||||||||
Generics |
APIs |
Devices |
Others |
||||||
Corporate Business Overview
Clients' Composition (%) |
Big Pharmas |
Mid or Small -Size Pharmas |
Biotech Companies |
Start-ups |
||||
In-house Facilities |
Research & Development |
Preclinical |
Clinical |
Custom Manufacturing |
Custom Sales |
|||
Focusing Therapeutic Area |
||||||||
General Overview of Corporate's Key Contract Services |
||||||||
Contract Service Capacity Affordable by Service Area |
||||||||
Communication with Clients |
Dispositoion of Project Manager Responsible |
|||||||
Providing Realtime Service Delivery |
||||||||
Realtime Feed-back |
||||||||
Corporate Competitiveness
Corporate Competitiveness |
|||||
No. of Regulatory Inspections |
Classification |
FDA(US) |
EMA(EU) |
PMDA(Japan) |
Others |
Pre-Clinical Area |
|||||
Clinical Area |
|||||
Manufacturing Area |
|||||
Others |
|||||
Current Status of Accredited Certification |
Collaboration Experiences with Asian Pharmaceutical & Biotech Companies
in recent 3 years
Countries which clients belong to |
Our clients include companies and organizations from Singapore, Malaysia, China, Thailand, Japan, South Korea, Taiwan, Hong Kong, Sri Lanka, Laos |
||||||||
Asian Clients' Composition (%) |
Big Pharmas |
Mid or Small -Size Pharmas |
Biotech Companies |
Start-ups |
|||||
No. of Asian Clients in recent 3 years |
We have represented a wide array of Asian clients in the last three years. Some of our representations include: |
||||||||
Major Service Range with Asian Companies |
Contract Research & Development |
Contract Manufacturing |
Contract Sales & Marketing |
Consulting |
|||||
Research |
API |
APIs |
R&D |
||||||
Pre-Clinical |
R&D Strategy & Management |
||||||||
Pre-clinical Test Sample |
|||||||||
Phase I |
Clinical Trials |
||||||||
Phase II |
Clinical Test Sample |
Finished Products |
Regulatory Affairs |
||||||
Phase III |
Business Development |
||||||||
Finished Product |
|||||||||
Phase IV |
Sales & Marketing |
|
|||||||
|
- 이전글 [국외CRO]Shin Nippon Biomedical Laboratories(SNBL)
- 다음글 다음글이 없습니다.